Clinical Trial Update: The Preterm Infants' Paracetamol Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating paracetamol for treating persistent ductus arteriosus in preterm infants has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complication of Prematurity
• Pain or Discomfort in Intensive Care of Preterm Infants
• Persistent Ductus Arteriosus

Drugs mentioned

• Paracetamol (acetaminophen)

Snippet

Sponsor: University of Oulu | Conditions: Persistent Ductus Arteriosus, Complication of Prematurity | Phase 2 | Status: COMPLETED